{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:56:39Z","timestamp":1780332999287,"version":"3.54.1"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T00:00:00Z","timestamp":1645056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>There seems to be a bidirectional interplay between Diabetes mellitus (DM) and coronavirus disease 2019 (COVID-19). On the one hand, people with diabetes are at higher risk of fatal or critical care unit-treated COVID-19 as well as COVID-19 related health complications compared to individuals without diabetes. On the other hand, clinical data so far suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may result in metabolic dysregulation and in impaired glucose homeostasis. In addition, emerging data on new onset DM in previously infected with SARS-CoV-2 patients, reinforce the hypothesis of a direct effect of SARS-CoV-2 on glucose metabolism. Attempting to find the culprit, we currently know that the pancreas and the endothelium have been found to express Angiotensin-converting enzyme 2 (ACE2) receptors, the main binding site of the virus. To move from bench to bedside, understanding the effects of COVID-19 on metabolism and glucose homeostasis is crucial to prevent and manage complications related to COVID-19 and support recovering patients. In this article we review the potential underlying pathophysiological mechanisms between COVID-19 and glucose dysregulation as well as the effects of antidiabetic treatment in patients with diabetes and COVID-19.<\/jats:p>","DOI":"10.3389\/fendo.2022.780663","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T08:06:24Z","timestamp":1645085184000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":68,"title":["Diabetes and COVID-19; A Bidirectional Interplay"],"prefix":"10.3389","volume":"13","author":[{"given":"Paraskevi","family":"Kazakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaia","family":"Lambadiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignatios","family":"Ikonomidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Kountouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Panagopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Athanasopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Korompoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kalomenidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios A.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimina","family":"Mitrakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and Impact of Cardiovascular Metabolic Diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154217","article-title":"Commentary: COVID-19 in Patients With Diabetes","volume":"107","author":"Hill","year":"2020","journal-title":"Metab Clin Exp"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154224","article-title":"Letter to the Editor: COVID-19 in Patients With Diabetes: Risk Factors That Increase Morbidity","volume":"108","author":"Klonoff","year":"2020","journal-title":"Metab Clin Exp"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients With COVID-19 - US, February 12-March 28, 2020","volume":"69","author":"Chow","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical Course and Outcomes of Critically Ill Patients With SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of Type 1 and Type 2 Diabetes With COVID-19-Related Mortality in England: A Whole-Population Study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors Associated With COVID-19-Related Death Using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0184","article-title":"Early and Late Endocrine Complications of COVID-19","volume":"10","author":"Kazakou","year":"2021","journal-title":"Endocr Connect"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk Factors for COVID-19-Related Mortality in People With Type 1 and Type 2 Diabetes in England: A Population-Based Cohort Study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic Characteristics and Prognosis of Inpatients With COVID-19 and Diabetes: The CORONADO Study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","article-title":"Risks of and Risk Factors for COVID-19 Disease in People With Diabetes: A Cohort Study of the Total Population of Scotland","volume":"9","author":"McGurnaghan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1210\/er.2003-0018","article-title":"From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors\/Cytokines","volume":"25","author":"Schrijvers","year":"2004","journal-title":"Endocr Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.immuni.2021.05.002","article-title":"Distinct Immunological Signatures Discriminate Severe COVID-19 From Non-SARS-CoV-2-Driven Critical Pneumonia","volume":"54","author":"Kreutmair","year":"2021","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr023045","article-title":"Hemoglobin and the Paracrine and Endocrine Functions of Nitric Oxide","volume":"348","author":"Schechter","year":"2003","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/288373a0","article-title":"The Obligatory Role of Endothelial Cells in the Relaxation of Arterial Smooth Muscle by Acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial Function and Dysfunction: Testing and Clinical Relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2007.02.002","article-title":"Endothelial Glycocalyx: Sweet Shield of Blood Vessels","volume":"17","author":"VanTeeffelen","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12013-007-0041-6","article-title":"A Role for the Endothelial Glycocalyx in Regulating Microvascular Permeability in Diabetes Mellitus","volume":"49","author":"Perrin","year":"2007","journal-title":"Cell Biochem Biophys"},{"key":"B21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11892-011-0182-2","article-title":"Human Vascular Endothelial Cells: A Model System for Studying Vascular Inflammation in Diabetes and Atherosclerosis","volume":"11","author":"Onat","year":"2011","journal-title":"Curr Diabetes Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2012.0011","article-title":"The Glycocalyx and Cardiovascular Disease in Diabetes: Should We Judge the Endothelium by Its Cover","volume":"14","author":"Lemkes","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.02.06.db05-1103","article-title":"Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo","volume":"55","author":"Nieuwdorp","year":"2006","journal-title":"Diabetes"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/792393","article-title":"Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus","volume":"2010","author":"van den Oever","year":"2010","journal-title":"Mediators Inflamm"},{"key":"B25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/jcm8070983","article-title":"Effects of Different Antidiabetic Medications on Endothelial Glycocalyx, Myocardial Function, and Vascular Function in Type 2 Diabetic Patients: One Year Follow\u2013Up Study","volume":"8","author":"Lambadiari","year":"2019","journal-title":"J Clin Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.01.056","article-title":"Early Detection of Left Ventricular Dysfunction in First-Degree Relatives of Diabetic Patients by Myocardial Deformation Imaging: The Role of Endothelial Glycocalyx Damage","volume":"233","author":"Ikonomidis","year":"2017","journal-title":"Int J Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 Diabetes as an Inflammatory Disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000345107","article-title":"Diabetes and Infection: Is There a Link? - A Mini-Review","volume":"59","author":"Knapp","year":"2013","journal-title":"Gerontology"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-3008","article-title":"Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes","volume":"38","author":"Grossmann","year":"2015","journal-title":"Diabetes Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.94253","article-title":"Infections in Patients With Diabetes Mellitus: A Review of Pathogenesis","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13002","article-title":"Relationship Between Natural Killer Cell Activity and Glucose Control in Patients With Type 2 Diabetes and Prediabetes","volume":"10","author":"Kim","year":"2019","journal-title":"J Diabetes Invest"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05209-1","article-title":"Fasting Blood Glucose at Admission Is an Independent Predictor for 28-Day Mortality in Patients With COVID-19 Without Previous Diagnosis of Diabetes: A Multi-Centre Retrospective Study","volume":"63","author":"Wang","year":"2020","journal-title":"Diabetologia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001476","article-title":"Elevation of Blood Glucose Level Predicts Worse Outcomes in Hospitalized Patients With COVID-19: A Retrospective Cohort Study","volume":"8","author":"Wu","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820924469","article-title":"Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States","volume":"14","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108561","article-title":"High Admission Blood Glucose Independently Predicts Poor Prognosis in COVID-19 Patients: A Systematic Review and Dose-Response Meta-Analysis","volume":"171","author":"Lazarus","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a Risk Factor for the Progression and Prognosis of COVID-19","volume":"36","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s13054-020-03255-0","article-title":"Longitudinal Changes of Inflammatory Parameters and Their Correlation With Disease Severity and Outcomes in Patients With COVID-19 From Wuhan, China","volume":"24","author":"Zeng","year":"2020","journal-title":"Crit Care (London England)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cmet.2020.07.007","article-title":"Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response Through a HIF-1\u03b1\/Glycolysis-Dependent Axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.05.005","article-title":"Negative Impact of Hyperglycaemia on Tocilizumab Therapy in Covid-19 Patients","volume":"46","author":"Marfella","year":"2020","journal-title":"Diabetes Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma Glucose Levels and Diabetes are Independent Predictors for Mortality and Morbidity in Patients With SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabetic Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS Coronavirus to Its Receptor Damages Islets and Causes Acute Diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570","article-title":"Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-Coronavirus Modulation of Myocardial ACE2 Expression and Inflammation in Patients With SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 Expression in Human Heart Indicates New Potential Mechanism of Heart Injury Among Patients Infected With SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.557235\/full","article-title":"Pre-Existing Cytokine and NLRP3 Inflammasome Activation and Increased Vascular Permeability in Diabetes: A Possible Fatal Link With Worst COVID-19 Infection Outcomes","volume":"11","author":"Lambadiari","year":"2020","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137244","article-title":"Clinical and Immunological Features of Severe and Moderate Coronavirus Disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000115557.25127.8D","article-title":"Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor","volume":"94","author":"Wassmann","year":"2004","journal-title":"Circ Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13054-015-0741-z","article-title":"Glycocalyx and Sepsis-Induced Alterations in Vascular Permeability","volume":"19","author":"Chelazzi","year":"2015","journal-title":"Crit Care"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2326","article-title":"Association of COVID-19 With Impaired Endothelial Glycocalyx, Vascular Function and Myocardial Deformation 4 Months After Infection","volume":"23","author":"Lambadiari","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B51","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","article-title":"Complex Immune Dysregulation in COVID-19 Patients With Severe Respiratory Failure","volume":"27","author":"Giamarellos-Bourboulis","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B52","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in Patients Hospitalized With Covid-19 Pneumonia","volume":"384","author":"Salama","year":"2021","journal-title":"N Engl J Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/path.2067","article-title":"Expression of Elevated Levels of Pro-Inflammatory Cytokines in SARS-CoV-Infected ACE2 + Cells in SARS Patients: Relation to the Acute Lung Injury and Pathogenesis of SARS","volume":"210","author":"He","year":"2006","journal-title":"J Pathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial Cell Infection and Endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.jaci.2017.11.043","article-title":"Glucagon-Like Peptide 1 Signaling Inhibits Allergen-Induced Lung IL-33 Release and Reduces Group 2 Innate Lymphoid Cell Cytokine Production In Vivo","volume":"142","author":"Toki","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06057-8","article-title":"Time to Consider Histologic Pattern of Lung Injury to Treat Critically Ill Patients With COVID-19 Infection","volume":"46","author":"Copin","year":"2020","journal-title":"Intensive Care Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60553-5","article-title":"Stress Hyperglycaemia","volume":"373","author":"Dungan","year":"2009","journal-title":"Lancet (London England)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2018.79.11.634","article-title":"Stress-Induced Hyperglycaemia","volume":"79","author":"Mifsud","year":"2018","journal-title":"Br J Hosp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.immuni.2018.05.005","article-title":"Virus-Induced Interferon-\u03b3 Causes Insulin Resistance in Skeletal Muscle and Derails Glycemic Control in Obesity","volume":"49","author":"\u0160estan","year":"2018","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic Human Coronavirus Infections: Causes and Consequences of Cytokine Storm and Immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114142","article-title":"Glucose and Free Fatty Acid Metabolism in Non-Insulin-Dependent Diabetes Mellitus. Evidence for Multiple Sites of Insulin Resistance","volume":"84","author":"Groop","year":"1989","journal-title":"J Clin Invest"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa342","article-title":"A Pragmatic Approach to Inpatient Diabetes Management During the COVID-19 Pandemic","volume":"105","author":"Korytkowski","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01276-8","article-title":"COVID-19 and the Endocrine System: Exploring the Unexplored","volume":"43","author":"Pal","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"B64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41574-020-00435-4","article-title":"COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management","volume":"17","author":"Lim","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in People With Diabetes: Understanding the Reasons for Worse Outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa011","article-title":"Coronavirus Infections and Type 2 Diabetes\u2014Shared Pathways With Therapeutic Implications","volume":"41","author":"Drucker","year":"2020","journal-title":"Endocr Rev"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2018688","article-title":"New-Onset Diabetes in Covid-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N Engl J Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14099","article-title":"Newly Diagnosed Diabetes is Associated With a Higher Risk of Mortality Than Known Diabetes in Hospitalized Patients With COVID -19","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108166","article-title":"Diabetic Ketoacidosis Precipitated by Covid-19 in a Patient With Newly Diagnosed Diabetes Mellitus","volume":"164","author":"Chee","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14328","article-title":"Guidance on the Management of Diabetic Ketoacidosis in the Exceptional Circumstances of the COVID-19 Pandemic","volume":"37","author":"Rayman","year":"2020","journal-title":"Diabetic Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14057","article-title":"COVID -19 Infection may Cause Ketosis and Ketoacidosis","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14269","article-title":"Proportion of Newly Diagnosed Diabetes in COVID-19 Patients: A Systematic Review and Meta-Analysis","volume":"23","author":"Sathish","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2020.0091","article-title":"Acute Hyperglycemic Crises With Coronavirus Disease-19: Case Reports","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of Blood Glucose Control and Outcomes in Patients With COVID-19 and Pre-Existing Type 2 Diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2020.13445","article-title":"Ketoacidosis in Children and Adolescents With Newly Diagnosed Type 1 Diabetes During the COVID-19 Pandemic in Germany","volume":"324","author":"Kamrath","year":"2020","journal-title":"JAMA"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1321","article-title":"Has COVID-19 Delayed the Diagnosis and Worsened the Presentation of Type 1 Diabetes in Children","volume":"43","author":"Rabbone","year":"2020","journal-title":"Diabetes Care"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1633","article-title":"Did the COVID-19 Lockdown Affect the Incidence of Pediatric Type 1 Diabetes in Germany","volume":"43","author":"Tittel","year":"2020","journal-title":"Diabetes Care"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(20)30108-5","article-title":"Delayed Access or Provision of Care in Italy Resulting From Fear of COVID-19","volume":"4","author":"Lazzerini","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1551","article-title":"New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K","volume":"43","author":"Unsworth","year":"2020","journal-title":"Diabetes Care"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-00281-8","article-title":"Autoantibody-Negative Insulin-Dependent Diabetes Mellitus After SARS-CoV-2 Infection: A Case Report","volume":"2","author":"Hollstein","year":"2020","journal-title":"Nat Metab"},{"key":"B81","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4314\/ahs.v14i3.5","article-title":"Glycosylated Haemoglobin I Markedly Elevated in New and Known Diabetes Patients With Hyperglycaemic Ketoacidosis","volume":"14","author":"Ekpebegh","year":"2014","journal-title":"Afr Health Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40249-020-00662-x","article-title":"Expression of the SARS-CoV-2 Cell Receptor Gene ACE2 in a Wide Variety of Human Tissues","volume":"9","author":"Li","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional Assessment of Cell Entry and Receptor Usage for SARS-CoV-2 and Other Lineage B Betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2312-y","article-title":"The Pathogenicity of SARS-CoV-2 in Hace2 Transgenic Mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209610","article-title":"The Protein Expression Profile of ACE2 in Human Tissues","volume":"16","author":"Hikmet","year":"2020","journal-title":"Mol Syst Biol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0237-2","article-title":"A Metabolic Handbook for the COVID-19 Pandemic","volume":"2","author":"Ayres","year":"2020","journal-title":"Nat Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 Expression in Pancreas May Cause Pancreatic Damage After SARS-CoV-2 Infection","volume":"18","author":"Liu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2020.1833263","article-title":"Association Between Acute Pancreatitis and COVID-19: Could Pancreatitis Be the Missing Piece of the Puzzle About Increased Mortality Rates","volume":"35","author":"Akarsu","year":"2020","journal-title":"J Invest Surg"},{"key":"B90","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 Infects and Replicates in Cells of the Human Endocrine and Exocrine Pancreas","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Nat Metab"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","article-title":"SARS-CoV-2 Infects Human Pancreatic \u03b2 Cells and Elicits \u03b2 Cell Impairment","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","article-title":"SARS-CoV-2 Infection Induces Beta Cell Transdifferentiation","volume":"33","author":"Tang","year":"2021","journal-title":"Cell Metab"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-020-0440-5","article-title":"Angiotensin-Converting Enzyme 2 Influences Pancreatic and Renal Function in Diabetic Mice","volume":"100","author":"Roca-Ho","year":"2020","journal-title":"Lab Invest"},{"key":"B95","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.metabol.2017.12.003","article-title":"Activation of ACE2\/angiotensin (1\u20137) Attenuates Pancreatic \u03b2 Cell Dedifferentiation in a High-Fat-Diet Mouse Model","volume":"81","author":"Xuan","year":"2018","journal-title":"Metab Clin Exp"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00054.2015","article-title":"ACE2 Deficiency Reduces \u03b2-Cell Mass and Impairs \u03b2-Cell Proliferation in Obese C57BL\/6 Mice","volume":"309","author":"Shoemaker","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2014.1917","article-title":"The Angiotensin-Converting Enzyme 2\/Angiotensin (1-7)\/Mas Axis Protects the Function of Pancreatic \u03b2 Cells by Improving the Function of Islet Microvascular Endothelial Cells","volume":"34","author":"Lu","year":"2014","journal-title":"Int J Mol Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","article-title":"Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals With COVID-19","volume":"32","author":"Kusmartseva","year":"2020","journal-title":"Cell Metab"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.cmet.2020.11.006","article-title":"SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas But Are Not Enriched in \u03b2 Cells","volume":"32","author":"Coate","year":"2020","journal-title":"Cell Metab"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2020.596898","article-title":"SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic \u03b2-Cells and in the Human Pancreas Microvasculature","volume":"11","author":"Fignani","year":"2020","journal-title":"Front Endocrinol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1038\/s41467-021-23886-3","article-title":"Viral Infiltration of Pancreatic Islets in Patients With COVID-19","volume":"12","author":"Steenblock","year":"2021","journal-title":"Nat Commun"},{"key":"B102","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-Wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection","volume":"184","author":"Wei","year":"2021","journal-title":"Cell"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 Facilitates SARS-CoV-2 Cell Entry and Infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1159\/000368486","article-title":"Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus","volume":"40","author":"Liang","year":"2015","journal-title":"Kidney Blood Pressure Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2014-0065","article-title":"Urinary ACE2 in Healthy Adults and Patients With Uncomplicated Type 1 Diabetes","volume":"92","author":"Cherney","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical Recommendations for the Management of Diabetes in Patients With COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108132","article-title":"COVID-19, Diabetes Mellitus and ACE2: The Conundrum","volume":"162","author":"Pal","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The Biology of Incretin Hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl Peptidase 4 Is a Functional Receptor for the Emerging Human Coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01890-13","article-title":"Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2","volume":"87","author":"Shirato","year":"2013","journal-title":"J Virol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1739565","article-title":"Emerging COVID-19 Coronavirus: Glycan Shield and Structure Prediction of Spike Glycoprotein and Its Interaction With Human CD26","volume":"9","author":"Vankadari","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101160","article-title":"The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike","volume":"23","author":"Li","year":"2020","journal-title":"iScience"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.09.005","article-title":"Effects of SGLT2 Inhibitors on Systemic and Tissue Low-Grade Inflammation: The Potential Contribution to Diabetes Complications and Cardiovascular Disease","volume":"44","author":"Bonnet","year":"2018","journal-title":"Diabetes Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1721","article-title":"SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications","volume":"41","author":"Meyer","year":"2018","journal-title":"Diabetes Care"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.159","article-title":"Acute Kidney Injury From SGLT2 Inhibitors: Potential Mechanisms","volume":"12","author":"Hahn","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2020.11.019","article-title":"Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors","volume":"7","author":"Vitale","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa360","article-title":"Diabetic Ketoacidosis in COVID-19: Unique Concerns and Considerations","volume":"105","author":"Palermo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in Patients With Cardiometabolic Risk Factors Hospitalised With COVID-19 (DARE-19): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1177\/1461444810365020","article-title":"Thiazolidinediones","volume":"351","author":"Yki-J\u00e4rvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1172\/JCI10370","article-title":"Peroxisome Proliferator-Activated Receptor \u03b3 Ligands Inhibit Development of Atherosclerosis in LDL Receptor-Deficient Mice","volume":"106","author":"Li","year":"2000","journal-title":"J Clin Invest"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone After Ischemic Stroke or Transient Ischemic Attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr Rev"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and Diabetes: Can DPP4 Inhibition Play a Role","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B124","doi-asserted-by":"publisher","first-page":"e131774","DOI":"10.1172\/jci.insight.131774","article-title":"Comorbid Diabetes Results in Immune Dysregulation and Enhanced Disease Severity Following MERS-CoV Infection","volume":"4","author":"Kulcsar","year":"2019","journal-title":"JCI Insight"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00031.2018","article-title":"DPP4 Inhibition by Sitagliptin Attenuates LPS-Induced Lung Injury in Mice","volume":"315","author":"Kawasaki","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2018.03.015","article-title":"Reduction of Soluble Dipeptidyl Peptidase 4 Levels in Plasma of Patients Infected With Middle East Respiratory Syndrome Coronavirus","volume":"518","author":"Inn","year":"2018","journal-title":"Virology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02935-13","article-title":"Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus","volume":"88","author":"Raj","year":"2014","journal-title":"J Virol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study","volume":"43","author":"Solerte","year":"2020","journal-title":"Diabetes Care"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1340","article-title":"Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy","volume":"43","author":"Mirani","year":"2020","journal-title":"Diabetes Care"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa098","article-title":"The Association of Hypertension and Diabetes Pharmacotherapy With COVID-19 Severity and Immune Signatures: An Observational Study","volume":"7","author":"Dalan","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B131","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/dom.13850","article-title":"Diabetes Drugs and Stroke Risk: Intensive Versus Conventional Glucose-Lowering Strategies, and Implications of Recent Cardiovascular Outcome Trials","volume":"22","author":"Lim","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvw213","article-title":"Attenuation of Carotid Neointimal Formation After Direct Delivery of a Recombinant Adenovirus Expressing Glucagon-Like Peptide-1 in Diabetic Rats","volume":"113","author":"Lim","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of Action and Therapeutic Application of Glucagon-Like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab"},{"key":"B134","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s13054-018-2197-4","article-title":"Systematic Review of Incretin Therapy During Peri-Operative and Intensive Care","volume":"22","author":"Hulst","year":"2018","journal-title":"Crit Care (London England)"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201808_15737","article-title":"Metformin Relieves Acute Respiratory Distress Syndrome by Reducing miR-138 Expression","volume":"22","author":"Yu","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308445","article-title":"Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status","volume":"119","author":"Cameron","year":"2016","journal-title":"Circ Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30021-8","article-title":"Metformin to Reduce Metabolic Complications and Inflammation in Patients on Systemic Glucocorticoid Therapy: A Randomised, Double-Blind, Placebo-Controlled, Proof-of-Concept, Phase 2 Trial","volume":"8","author":"Pernicova","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.600439\/full","article-title":"Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes","volume":"11","author":"Crouse","year":"2020","journal-title":"medRxiv Preprint Server Health Sci"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.07.006","article-title":"Metformin and COVID-19: From Cellular Mechanisms to Reduced Mortality","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab067","article-title":"Association of Metformin With Susceptibility to COVID-19 in People With Type 2 Diabetes","volume":"106","author":"Wang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0723","article-title":"Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control","volume":"43","author":"Sardu","year":"2020","journal-title":"Diabetes Care"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021478","article-title":"Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels","volume":"88","author":"Hansen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1177\/1932296820932903","article-title":"Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic","volume":"14","author":"Galindo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2085","article-title":"Remote Continuous Glucose Monitoring With a Computerized Insulin Infusion Protocol for Critically Ill Patients in a COVID-19 Medical ICU: Proof of Concept","volume":"44","author":"Davis","year":"2021","journal-title":"Diabetes Care"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-2219","article-title":"Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic","volume":"44","author":"Agarwal","year":"2021","journal-title":"Diabetes Care"},{"key":"B146","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ecl.2019.11.002","article-title":"Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia","volume":"49","author":"Davis","year":"2020","journal-title":"Endocrinol Metab Clinics North Am"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1205","article-title":"Comment on Chen Et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399\u20131407","volume":"43","author":"Cariou","year":"2020","journal-title":"Diabetes Care"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0660","article-title":"Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"key":"B149","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S2213-8587(21)00050-4","article-title":"Prescription of Glucose-Lowering Therapies and Risk of COVID-19 Mortality in People With Type 2 Diabetes: A Nationwide Observational Study in England","volume":"9","author":"Khunti","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001621","article-title":"Psychiatric Symptoms in Acute Respiratory Distress Syndrome Survivors: A 1-Year National Multicenter Study","volume":"44","author":"Huang","year":"2016","journal-title":"Crit Care Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-016-4530-1","article-title":"Physical Declines Occurring After Hospital Discharge in ARDS Survivors: A 5-Year Longitudinal Study","volume":"42","author":"Pfoh","year":"2016","journal-title":"Intensive Care Med"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10145","article-title":"Sepsis Induces Long-Term Metabolic and Mitochondrial Muscle Stem Cell Dysfunction Amenable by Mesenchymal Stem Cell Therapy","volume":"6","author":"Rocheteau","year":"2015","journal-title":"Nat Commun"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3201\/eid2610.202225","article-title":"Rhabdomyolysis as Potential Late Complication Associated With COVID-19","volume":"26","author":"Chan","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B154","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered Lipid Metabolism in Recovered SARS Patients Twelve Years After Infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"B155","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.3390\/jcm10132945","article-title":"Long-Term Outcomes of Patients With Coronavirus Disease 2019 at One Year After Hospital Discharge","volume":"10","author":"Maestre-Mu\u00f1iz","year":"2021","journal-title":"J Clin Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.780663\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T08:06:28Z","timestamp":1645085188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.780663\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,17]]},"references-count":155,"alternative-id":["10.3389\/fendo.2022.780663"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.780663","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,17]]},"article-number":"780663"}}